125853.G.43.1 | United Arab Emirates | 78 | NA | Association | Type 2 Diabetes Mellitus | Al Safar et al. 2018 | Study with 264 unrelated T2DM patients (... |
125853.G.43.2 | United Arab Emirates | 78 | NA | | | Al Safar et al. 2018 | Control group comprising 90 subjects (68... |
176807.G.1.1 | Lebanon | 77 | 0.56 | Benign | Prostate Cancer | El Ezzi et al. 2017 | 69 patients with confirmed prostate canc... |
176807.G.1.2 | Lebanon | 83 | 0.60 | Benign | | El Ezzi et al. 2017 | 69 Lebanese control subjects |
600082.G.1.1 | Lebanon | | 0.0.42 | Association | Prostatic Hyperplasia, Benign | El Ezzi et al. 2014 | 68 patients with BPH. VDR SNPs (c.2T>G) ... |
600082.G.1.2 | Lebanon | | 0.58 | | | El Ezzi et al. 2014 | 79 Lebanese controls |
601665.G.2.2 | United Arab Emirates | NA | 0.514 | | Obesity | Khan et al. 2018 | Study with 414 overweight/obese subjects... |
601769.G.2.1 | Lebanon | 158 | 0.43 | Association | | Hajj et al. 2016 | Group of healthy individuals including 6... |
601769.G.3.1 | Lebanon | 96 | | Benign | | Arabi et al. 2009 | VDR polymorphisms (using Bsm1 and Taq1 e... |
601769.G.3.2 | Lebanon | 88 | | Benign | | Arabi et al. 2009 | VDR polymorphisms (using Bsm1 and Taq1 e... |
601769.G.4.1 | Lebanon | 169 | 0.33 | Benign | | Arabi et al. 2010 | Study on healthy individuals. Heterozygo... |
601769.G.4.2 | Lebanon | 220 | 0.33 | Benign | | Arabi et al. 2010 | Study on healthy individuals. Heterozygo... |